Abattis Biologix is a specialty biotechnology company engaged in the development, licensing, sale and distribution of botanical-based antiviral products. At present, the Company is focused on refining and bringing to market a proprietary nutraceutical formulation of botanical agents with demonstrated ability to inhibit the growth of, and reduce the severity and duration of various strains of human influenza and other viral diseases. Continuing research is being conducted at the Institute for Antiviral Research, Utah State University.
